Skip to content

Oruka Therapeutics, Inc. ORKA Issuance of warrants

Issuance of warrants at other companies

Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$2.52M-75.7%
Applied Digital logo
Applied DigitalAPLD
$121.2M+232%
KEE
Keel Infrastructure Corp. Common StockKEEL
$11.48M
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$2.52M-75.7%
BILL Holdings logo
BILL HoldingsBILL
$3.28M+50.0%
Paychex logo
PaychexPAYX
$1.05B

Other financials

Income statement

See full
Revenue-
Operating income-$36.4M-45.2%
Net income-$31.8M-51.5%
EPS (diluted)-$0.46+93.4%

Balance sheet

See full
Cash & equivalents$49.5M-40.7%
Total debt$1.8M+90.8%
Total equity$486.7M+33.4%
Total assets$504.5M+33.8%

Cash flow

See full
Operating cash flow-$23.6M-13.0%
CapEx$73.0K+462%
Free cash flow-$23.7M-13.3%

Valuation

See full
Market cap$5.03B+533%

Returns & leverage

See full
Return on equity-27.3%-11.1pp
Debt / equity0.0×
Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued.

The official record: Oruka Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oruka Therapeutics, Inc.'s issuance of warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oruka Therapeutics, Inc.'s issuance of warrants?
Oruka Therapeutics, Inc. (ORKA) reported issuance of warrants of $2.52M in Q4 2025.
How has Oruka Therapeutics, Inc.'s issuance of warrants changed year-over-year?
Oruka Therapeutics, Inc.'s issuance of warrants decreased by 75.7% year-over-year, from $10.36M to $2.52M.
What does issuance of warrants mean?
Represents the accounting adjustments made to additional paid-in capital related to the issuance of warrants. This captures the equity component of financing arrangements that include derivative features.